Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

March 1, 1995; Volume 154,Issue 5

ARTICLES

  • You have accessRestricted access
    Engagement of the vitronectin receptor (alpha V beta 3) on murine T cells stimulates tyrosine phosphorylation of a 115-kDa protein.
    C Brando and E M Shevach
    J Immunol March 1, 1995, 154 (5) 2005-2011;
  • You have accessRestricted access
    AD2, a human molecule involved in the interaction of T cells with epidermal keratinocytes and thymic epithelial cells.
    C S Bruggers, D D Patel, R M Scearce, L P Whichard, B F Haynes and K H Singer
    J Immunol March 1, 1995, 154 (5) 2012-2022;
  • You have accessRestricted access
    Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity.
    V K Chiu, C M Walsh, C C Liu, J C Reed and W R Clark
    J Immunol March 1, 1995, 154 (5) 2023-2032;
  • You have accessRestricted access
    Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain.
    M A Goldsmith, M C Amaral and W C Greene
    J Immunol March 1, 1995, 154 (5) 2033-2040;
  • You have accessRestricted access
    Mitogen activation of a nuclear alkaline phosphatase in normal activated lymphocytes.
    A L Kenter and L Morgan
    J Immunol March 1, 1995, 154 (5) 2041-2050;
  • You have accessRestricted access
    Early appearance of "natural" mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies.
    D R Kramer and J J Cebra
    J Immunol March 1, 1995, 154 (5) 2051-2062;
  • You have accessRestricted access
    Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.
    P F Mixter, J Q Russell, F H Durie and R C Budd
    J Immunol March 1, 1995, 154 (5) 2063-2074;
  • You have accessRestricted access
    T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction.
    R M O'Hara Jr, M C Byrne, V K Kuchroo, A Nagelin, M J Whitters, S Jayaraman, S L Henderson, M E Dorf and M Collins
    J Immunol March 1, 1995, 154 (5) 2075-2081;
  • You have accessRestricted access
    Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
    S A Rico-Vargas, M Potter and D G Osmond
    J Immunol March 1, 1995, 154 (5) 2082-2091;
  • You have accessRestricted access
    B cell superstimulatory influenza virus (H2-subtype) induces B cell proliferation by a PKC-activating, Ca(2+)-independent mechanism.
    O Rott, J Charreire, M Semichon, G Bismuth and E Cash
    J Immunol March 1, 1995, 154 (5) 2092-2103;
  • You have accessRestricted access
    Antigen-independent, integrin-mediated T cell activation.
    K Sturmhöfel, C Brando, F Martinon, E M Shevach and J E Coligan
    J Immunol March 1, 1995, 154 (5) 2104-2111;
  • You have accessRestricted access
    Regulation of lymphocyte pseudopodia formation by triggering the integrin alpha 4/beta 1.
    M C Szabo, T K Teague and B W McIntyre
    J Immunol March 1, 1995, 154 (5) 2112-2124;
  • You have accessRestricted access
    Expression of a novel integrin beta 1 chain epitope and anti-beta 1 antibody-mediated enhancement of fibronectin binding are dependent on the stage of T cell differentiation.
    S A Wadsworth, A C Chang, M J Hong, M J Halvorson, S Otto and J E Coligan
    J Immunol March 1, 1995, 154 (5) 2125-2133;
  • You have accessRestricted access
    Murine minor histocompatibility antigens detected by helper T cells. Recognition of an endogenous peptide.
    P J Wettstein
    J Immunol March 1, 1995, 154 (5) 2134-2143;
  • You have accessRestricted access
    Restoring the apoptosis suppression response to IL-5 confers on erythroleukemic cells a phenotype of IL-5-dependent growth.
    J J Yen, Y C Hsieh, C L Yen, C C Chang, S Lin and H F Yang-Yen
    J Immunol March 1, 1995, 154 (5) 2144-2152;
  • You have accessRestricted access
    Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    M G Lichtenheld, E R Podack and R B Levy
    J Immunol March 1, 1995, 154 (5) 2153-2163;
  • You have accessRestricted access
    Isolation, primary structure, and evolution of the third component of chicken complement and evidence for a new member of the alpha 2-macroglobulin family.
    M Mavroidis, J O Sunyer and J D Lambris
    J Immunol March 1, 1995, 154 (5) 2164-2174;
  • You have accessRestricted access
    Recombination potential of the human DIR elements.
    B B Moore and K Meek
    J Immunol March 1, 1995, 154 (5) 2175-2187;
  • You have accessRestricted access
    Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    W Nietfield, M Bauer, M Fevrier, R Maier, B Holzwarth, R Frank, B Maier, Y Riviere and A Meyerhans
    J Immunol March 1, 1995, 154 (5) 2189-2197;
  • You have accessRestricted access
    Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    M Polymenis and B D Stollar
    J Immunol March 1, 1995, 154 (5) 2198-2208;
  • You have accessRestricted access
    Binding analysis of antibodies produced by precursor and branchpoint intermediates of an anti-influenza hemagglutinin B cell clone. Parallel replacement mutations do not confer increased avidity for hemagglutinin.
    R C Rickert, M K Wloch, R L Hahn and S H Clarke
    J Immunol March 1, 1995, 154 (5) 2209-2216;
  • You have accessRestricted access
    Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells.
    D Sigurdardottir, J Sohn, J Kass and E Selsing
    J Immunol March 1, 1995, 154 (5) 2217-2225;
  • You have accessRestricted access
    Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
    R I Smith, M J Coloma and S L Morrison
    J Immunol March 1, 1995, 154 (5) 2226-2236;
  • You have accessRestricted access
    Secondary deletional recombination of rearranged switch region in Ig isotype-switched B cells. A mechanism for isotype stabilization.
    K Zhang, H K Cheah and A Saxon
    J Immunol March 1, 1995, 154 (5) 2237-2247;
  • You have accessRestricted access
    Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
    S J Ralph, B D Wines, M J Payne, D Grubb, I Hatzinisiriou, A W Linnane and R J Devenish
    J Immunol March 1, 1995, 154 (5) 2248-2256;
  • You have accessRestricted access
    Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    L Rivoltini, Y Kawakami, K Sakaguchi, S Southwood, A Sette, P F Robbins, F M Marincola, M L Salgaller, J R Yannelli and E Appella
    J Immunol March 1, 1995, 154 (5) 2257-2265;
  • You have accessRestricted access
    Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    J W Rohrer, C Culpepper, A L Barsoum and J H Coggin Jr
    J Immunol March 1, 1995, 154 (5) 2266-2280;
  • You have accessRestricted access
    Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    N Yamamoto, J P Zou, X F Li, H Takenaka, S Noda, T Fujii, S Ono, Y Kobayashi, N Mukaida and K Matsushima
    J Immunol March 1, 1995, 154 (5) 2281-2290;
  • You have accessRestricted access
    Activation of human neutrophils through L-selectin and Mac-1 molecules.
    E Crockett-Torabi, B Sulenbarger, C W Smith and J C Fantone
    J Immunol March 1, 1995, 154 (5) 2291-2302;
  • You have accessRestricted access
    Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    R J Diefenbach and D E Isenman
    J Immunol March 1, 1995, 154 (5) 2303-2320;
  • You have accessRestricted access
    Human IL-1 beta processing and secretion in recombinant baculovirus-infected Sf9 cells is blocked by the cowpox virus serpin crmA.
    A D Howard, O C Palyha, P R Griffin, E P Peterson, A B Lenny, G J Ding, D J Pickup, N A Thornberry, J A Schmidt and M J Tocci
    J Immunol March 1, 1995, 154 (5) 2321-2332;
  • You have accessRestricted access
    Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts.
    M Kawai, R Nishikomori, E Y Jung, G Tai, C Yamanaka, M Mayumi and T Heike
    J Immunol March 1, 1995, 154 (5) 2333-2341;
  • You have accessRestricted access
    Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    C Mantel, S Aronica, Z Luo, M S Marshall, Y J Kim, S Cooper, N Hague and H E Broxmeyer
    J Immunol March 1, 1995, 154 (5) 2342-2350;
  • You have accessRestricted access
    Substrate specificities of the protease of mouse serum Ra-reactive factor.
    R T Ogata, P J Low and M Kawakami
    J Immunol March 1, 1995, 154 (5) 2351-2357;
  • You have accessRestricted access
    Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion.
    R A Panettieri Jr, A L Lazaar, E Puré and S M Albelda
    J Immunol March 1, 1995, 154 (5) 2358-2365;
  • You have accessRestricted access
    Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis.
    Y Ren and J Savill
    J Immunol March 1, 1995, 154 (5) 2366-2374;
  • You have accessRestricted access
    IL-8 specifically binds to endothelial but not to smooth muscle cells.
    U Schönbeck, E Brandt, F Petersen, H D Flad and H Loppnow
    J Immunol March 1, 1995, 154 (5) 2375-2383;
  • You have accessRestricted access
    Isolation of nine gene sequences induced by silica in murine macrophages.
    F Segade, E Claudio, K Wrobel, S Ramos and P S Lazo
    J Immunol March 1, 1995, 154 (5) 2384-2392;
  • You have accessRestricted access
    Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines.
    D Taub, J Dastych, N Inamura, J Upton, D Kelvin, D Metcalfe and J Oppenheim
    J Immunol March 1, 1995, 154 (5) 2393-2402;
  • You have accessRestricted access
    In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-alpha or cycloheximide.
    H Tsuchida, Y Takeda, H Takei, H Shinzawa, T Takahashi and F Sendo
    J Immunol March 1, 1995, 154 (5) 2403-2412;
  • You have accessRestricted access
    Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase.
    C J Vlahos, W F Matter, R F Brown, A E Traynor-Kaplan, P G Heyworth, E R Prossnitz, R D Ye, P Marder, J A Schelm and K J Rothfuss
    J Immunol March 1, 1995, 154 (5) 2413-2422;
  • You have accessRestricted access
    Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex.
    K A Bernstein, R D Valerio and J B Lefkowith
    J Immunol March 1, 1995, 154 (5) 2424-2433;
  • You have accessRestricted access
    Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    V Casini-Raggi, L Kam, Y J Chong, C Fiocchi, T T Pizarro and F Cominelli
    J Immunol March 1, 1995, 154 (5) 2434-2440;
  • You have accessRestricted access
    Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    C G Drake, S J Rozzo, H F Hirschfeld, N P Smarnworawong, E Palmer and B L Kotzin
    J Immunol March 1, 1995, 154 (5) 2441-2447;
  • You have accessRestricted access
    HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines.
    A L Kinter, G Poli, L Fox, E Hardy and A S Fauci
    J Immunol March 1, 1995, 154 (5) 2448-2459;
  • You have accessRestricted access
    A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes.
    D J Miller and M Rodriguez
    J Immunol March 1, 1995, 154 (5) 2460-2469;
  • You have accessRestricted access
    Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice.
    C F Morris, C J Simeonovic, M C Fung, J D Wilson and A J Hapel
    J Immunol March 1, 1995, 154 (5) 2470-2482;
  • You have accessRestricted access
    IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.
    R L Rubin, R W Burlingame, J E Arnott, M C Totoritis, E M McNally and A D Johnson
    J Immunol March 1, 1995, 154 (5) 2483-2493;
  • You have accessRestricted access
    Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
    P Santamaria, T Utsugi, B J Park, N Averill, S Kawazu and J W Yoon
    J Immunol March 1, 1995, 154 (5) 2494-2503;
  • You have accessRestricted access
    Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    S Wirth, L G Guidotti, K Ando, H J Schlicht and F V Chisari
    J Immunol March 1, 1995, 154 (5) 2504-2515;
  • You have accessRestricted access
    A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys.
    Y Yasutomi, S N McAdam, J E Boyson, M S Piekarczyk, D I Watkins and N L Letvin
    J Immunol March 1, 1995, 154 (5) 2516-2522;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 154, Issue 5
1 Mar 1995
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606